Ionis Pharmaceuticals, Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Ionis Pharmaceuticals, Inc. (IONS) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $1.89 per share for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-29.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2012-02-29
- Ionis Pharmaceuticals, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2009 was $1.89.
- Ionis Pharmaceuticals, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2008 was -$0.09.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|
| 2009-12-31 | $1.89 10-K · filed 2012-02-29 | ||
| 2009-09-30 | $1.91 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $1.91 10-Q · filed 2010-08-09 | ||
| 2008-12-31 | -$0.09 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |